A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone
type: MedicalStudy
description: An Open Label Phase 3 Study of Fortigel Testosterone Gel 2% in Hypogonadal Males
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2007-08
end date: 2008-03
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00522431
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Endo Pharmaceuticals
study subject: Hypogonadism
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Hypogonadism

AI Analytics
type: Organization